Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids

Details for Australian Patent Application No. 2001261695 (hide)

International Classifications

Event Publications

19 May 2005 Assignment before Grant

Manhattan Pharmaceuticals, Inc. The application has been assigned to Indevus Pharmaceuticals, Inc.

16 June 2005 Application Accepted

Published as AU-B-2001261695

13 October 2005 Standard Patent Sealed

11 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.